MedPath

REVANCE AUSTRALIA PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

TGA:1

Drug Approvals

DAXXIFY daxibotulinumtoxinA 100 units powder for injection vial (420430)

Product Name
DAXXIFY daxibotulinumtoxinA 100 units powder for Injection vial
Approval Date
Dec 17, 2024
TGA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath